Symposier - Kidney Impairment with Byetta (March 2010)
Links shared publicly online about this topic.
symposier.com —
Uploaded and Shared in Youtube by: LawsuitGuru To help clinicians weigh the benefits and risks of the diabetes drug Byetta (exenatide), FDA is requiring that information about the risk of renal impairment be added to the drug's labeling. From April 2005 to October 2008, FDA received 78 reports of altered kidney function in patients treated with Byetta. Some of the patients had pre-existing kidney disease and other risk factors for developing kidney problems. Acute renal failure occurred in
View full resource at symposier.com
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Kidney Health, Urinary System, Drug, FDA, Byetta
Most Recently Shared on March 28, 2012 at 10:45 am By: